$17.98
-0.65[-3.49%]
At close: Apr 25
$17.98
0[0.00%]
After Hours: 4:20PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/27/2024 | MYGN | Myriad Genetics | FY | 2024 | $0.00 | $0.05 | -$0.01 | $820.00M | $840.00M | $819.25M | Get Alert |
01/16/2024 | MYGN | Myriad Genetics | FY | 2023 | -$0.33 | -$0.28 | -$0.30 | $747.00M | $753.00M | $751.29M | Get Alert |
12/21/2023 | MYGN | Myriad Genetics | FY | 2024 | — | — | — | $815.00M | $835.00M | $818.63M | Get Alert |
12/21/2023 | MYGN | Myriad Genetics | FY | 2023 | -$0.33 | -$0.28 | -$0.30 | $747.00M | $753.00M | $750.90M | Get Alert |
11/06/2023 | MYGN | Myriad Genetics | FY | 2023 | -$0.33 | -$0.28 | -$0.31 | $747.00M | $753.00M | $739.52M | Get Alert |
08/03/2023 | MYGN | Myriad Genetics | FY | 2023 | -$0.36 | -$0.24 | -$0.32 | $730.00M | $750.00M | $742.12M | Get Alert |
05/03/2023 | MYGN | Myriad Genetics | FY | 2023 | -$0.36 | -$0.24 | -$0.32 | $730.00M | $750.00M | $732.49M | Get Alert |
02/28/2023 | MYGN | Myriad Genetics | FY | 2023 | -$0.40 | -$0.20 | -$0.30 | $720.00M | $750.00M | $724.97M | Get Alert |
02/28/2023 | MYGN | Myriad Genetics | Q1 | 2023 | -$0.20 | -$0.18 | -$0.10 | $170.00M | $172.00M | $174.88M | Get Alert |
11/01/2022 | MYGN | Myriad Genetics | FY | 2022 | -$0.35 | -$0.30 | -$0.06 | $668.00M | $672.00M | $692.18M | Get Alert |
08/04/2022 | MYGN | Myriad Genetics | FY | 2022 | -$0.10 | $0.00 | $0.03 | $670.00M | $700.00M | $686.67M | Get Alert |
05/05/2022 | MYGN | Myriad Genetics | FY | 2022 | $0.00 | $0.20 | $0.08 | $670.00M | $700.00M | $684.40M | Get Alert |
02/24/2022 | MYGN | Myriad Genetics | FY | 2022 | $0.00 | $0.20 | $0.15 | $670.00M | $700.00M | $675.19M | Get Alert |
02/06/2020 | MYGN | Myriad Genetics | FY | 2020 | $0.45 | $0.45 | $1.40 | $735.00M | $735.00M | $851.80M | Get Alert |
02/06/2020 | MYGN | Myriad Genetics | Q3 | 2020 | $0.02 | $0.02 | $0.30 | $172.00M | $172.00M | $201.22M | Get Alert |
11/04/2019 | MYGN | Myriad Genetics | FY | 2020 | $1.00 | $1.10 | $1.82 | $800.00M | $810.00M | $872.35M | Get Alert |
11/04/2019 | MYGN | Myriad Genetics | Q2 | 2020 | $0.30 | $0.32 | $0.48 | $210.00M | $212.00M | $221.35M | Get Alert |
08/13/2019 | MYGN | Myriad Genetics | Q1 | 2020 | $0.30 | $0.32 | $0.42 | $200.00M | $202.00M | $217.35M | Get Alert |
08/13/2019 | MYGN | Myriad Genetics | FY | 2020 | $1.80 | $1.90 | $1.92 | $865.00M | $875.00M | $921.99M | Get Alert |
The last reported Earnings numbers were from February 27, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $0.00 and $0.05 versus the estimated EPS of $-0.01.
Browse guidance and forecast on all stocks.